Author Archives: Rocio Gallegos, MD

A new study from researchers at the University of Colorado Anschutz Medical Campus finds that older adult drivers who are recently diagnosed with migraines are three times as likely to experience a motor vehicle crash.  “Migraine headaches affect more than 7% of U.S. adults over the age of 60,” says Carolyn DiGuiseppi, MPH, PhD, MD. […]

Bacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF), finds a new study led by researchers from the University of Michigan and the University of Virginia. Working under the hypothesis that treatment with antibiotics could improve outcomes in patients with the disease, the CleanUP-IPF study includes the collection of […]

Sparked by promising studies and stories of lives transformed, clinics offering intravenous infusions of ketamine have popped up nationwide. Some also offer a newer, more expensive, nasal spray version. But major questions remain about who ketamine can help, why some people get tremendous relief within days or weeks while others don’t, and the costs and […]

Physical inactivity can result in a weakening of the muscles (known as sarcopenia) and bones (known as osteoporosis). Exercise dispels this frailty, increasing muscle strength and promoting bone formation while suppressing bone resorption. However, exercise therapy cannot be applied to all clinical cases. Drug therapy may be helpful in treating sarcopenia and osteoporosis, especially when […]

Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. One key feature of the disease is that it causes the patient’s own immune system to attack and destroy the myelin sheaths in the central nervous system. Myelin sheaths ensure that electrical impulses travel quickly and efficiently from nerve cell to nerve […]

Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abello A/S have made a groundbreaking discovery: a new cell that remembers allergies. The discovery gives scientists and researchers a new target in treating allergies and could lead to new therapeutics. “We’ve discovered a type of memory B cell that had unique characteristics and a unique gene […]

Rheumatoid arthritis is the most common type of inflammatory arthritis and affects 18 million people worldwide. It is a complex autoimmune disease characterized by chronic inflammation. This inflammation can cause the destruction of cartilage and bone, eventually leading to limitations, disabilities, loss of function, decreased quality of life, and possibly shortened life expectancy. “A major […]